Sivik Global Healthcare LLC Has $4.21 Million Holdings in Avantor, Inc. (NYSE:AVTR)

Sivik Global Healthcare LLC trimmed its stake in Avantor, Inc. (NYSE:AVTR - Free Report) by 20.0% during the fourth quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 200,000 shares of the company's stock after selling 50,000 shares during the quarter. Avantor makes up 2.2% of Sivik Global Healthcare LLC's holdings, making the stock its 21st largest holding. Sivik Global Healthcare LLC's holdings in Avantor were worth $4,214,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other institutional investors and hedge funds also recently modified their holdings of the stock. Forsta AP Fonden raised its holdings in shares of Avantor by 3.3% during the fourth quarter. Forsta AP Fonden now owns 151,800 shares of the company's stock valued at $3,198,000 after acquiring an additional 4,900 shares during the period. Robeco Institutional Asset Management B.V. raised its stake in Avantor by 38.1% during the 4th quarter. Robeco Institutional Asset Management B.V. now owns 119,063 shares of the company's stock valued at $2,509,000 after purchasing an additional 32,838 shares during the period. CKW Financial Group lifted its holdings in shares of Avantor by 116.7% in the fourth quarter. CKW Financial Group now owns 5,200 shares of the company's stock valued at $110,000 after purchasing an additional 2,800 shares in the last quarter. Pacer Advisors Inc. boosted its position in shares of Avantor by 0.5% in the fourth quarter. Pacer Advisors Inc. now owns 99,825 shares of the company's stock worth $2,103,000 after buying an additional 542 shares during the period. Finally, Blue Trust Inc. grew its holdings in shares of Avantor by 6.9% during the fourth quarter. Blue Trust Inc. now owns 8,069 shares of the company's stock valued at $170,000 after buying an additional 522 shares in the last quarter. 95.08% of the stock is owned by institutional investors and hedge funds.

Avantor Stock Down 1.5 %

Shares of AVTR traded down $0.33 during trading hours on Monday, hitting $21.96. 4,961,586 shares of the company were exchanged, compared to its average volume of 4,723,532. The company has a debt-to-equity ratio of 0.84, a quick ratio of 1.06 and a current ratio of 1.54. The company has a market cap of $14.94 billion, a PE ratio of 47.80, a PEG ratio of 3.97 and a beta of 1.28. The firm's 50 day moving average is $21.69 and its 200-day moving average is $23.46. Avantor, Inc. has a 52 week low of $19.59 and a 52 week high of $28.00.

Analyst Upgrades and Downgrades

Several equities research analysts recently issued reports on the company. Robert W. Baird reduced their price objective on Avantor from $27.00 to $26.00 and set an "outperform" rating for the company in a research note on Monday, October 28th. Barclays raised their price target on shares of Avantor from $25.00 to $26.00 and gave the stock an "overweight" rating in a report on Monday. Raymond James dropped their price objective on shares of Avantor from $29.00 to $26.00 and set an "outperform" rating on the stock in a research note on Tuesday, January 21st. UBS Group reissued a "neutral" rating and set a $25.00 target price (down previously from $29.00) on shares of Avantor in a research note on Friday, January 17th. Finally, Wells Fargo & Company dropped their price target on shares of Avantor from $30.00 to $28.00 and set an "overweight" rating on the stock in a research note on Monday, October 28th. Three equities research analysts have rated the stock with a hold rating and ten have given a buy rating to the company's stock. Based on data from MarketBeat, the company currently has a consensus rating of "Moderate Buy" and a consensus target price of $27.46.

About Avantor

Avantor, Inc engages in the provision of mission-critical products and services to customers in the biopharma, healthcare, education and government, advanced technologies, and applied materials industries in the Americas, Europe, Asia, the Middle East, and Africa. The company offers materials and consumables, such as purity chemicals and reagents, lab products and supplies, formulated silicone materials, customized excipients, customized single-use assemblies, process chromatography resins and columns, analytical sample prep kits, education and microbiology products, clinical trial kits, peristaltic pumps, and fluid handling tips.